Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-12-12Idiopathic Pulmonary Fibrosis Job Exposures Study
-
CLINICAL_TRIALS study record update · 2019-11-21A Randomised, Placebo-controlled, Double-blind, Repeat Dose Escalation Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2019-11-19A Phase 2 Sequential, Ascending Dose Study to Characterize the Safety, Tolerability, Pharmacokinetic and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2019-11-13Korean Idiopathic Pulmonary Fibrosis Registry
-
CLINICAL_TRIALS study record update · 2019-10-09A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-09-27A Comparative Assessment of Measurements Made in an Incremental Shuttle Walk Test and Incremental Cycle Ergometry Test in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2019-09-25Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study
-
CLINICAL_TRIALS study record update · 2019-09-13IPF Italian Observational Study (FIBRONET)
-
CLINICAL_TRIALS study record update · 2019-08-28Azithromycin for the Treatment of Cough in Idiopathic Pulmonary Fibrosis- a Clinical Trial
-
CLINICAL_TRIALS study record update · 2019-08-12A Study of Single Doses to Evaluate the Safety, Tolerability, Pharmacokinetics and Target Engagement of Nebulised GSK3008348 in Idiopathic Pulmonary Fibrosis Patients, Using Positron Emission Tomography (PET) Imaging
-
CLINICAL_TRIALS study record update · 2019-08-08Assessment of the Reproducibility of the 3 Minutes Sit-to-stand Test in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2019-08-06A 12-week, Double Blind, Randomised, Placebo Controlled, Parallel Group Trial Followed by a Single Active Arm Phase of 40 Weeks Evaluating the Effect of Oral Nintedanib 150 mg Twice Daily on Change in Biomarkers of Extracellular Matrix (ECM) Turnover in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Limited Forced Vital Capacity (FVC) Impairment.
-
CLINICAL_TRIALS study record update · 2019-08-01A Multicentre, Retrospective Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain.
-
CLINICAL_TRIALS study record update · 2019-07-15A Randomized, Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of 28 Day Treatment With Fostair® Pressurized Metered-dose Inhaler (pMDI) 200/12 on Biomarkers of Platelet Adhesion in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2019-07-15Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden
-
CLINICAL_TRIALS study record update · 2019-07-10Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy
-
CLINICAL_TRIALS study record update · 2019-07-08Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2019-05-22Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2019-03-27Prospective Observation of Fibrosis in the Lung Clinical Endpoints (PROFILE_Brompton)Study
-
CLINICAL_TRIALS study record update · 2019-03-04Investigation of Drug-drug Interaction Between Nintedanib and Pirfenidone in Patients With IPF (an Open Label, Multiple-dose, Two Group Study)
-
CLINICAL_TRIALS study record update · 2019-02-15Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2019-02-15Development and Validation of Test for Gastro-esophageal Reflux and Aspiration
-
CLINICAL_TRIALS study record update · 2019-02-08Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2019-01-24Randomized, Double-blind, Placebo-controlled Study of the Tolerability and Pharmacokinetics of Ascending Single and 14-day Repeated Oral Doses of ZL-2102 With a Pilot Investigation of Food Effect in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2019-01-23The Impact of Air Pollution on Chronic Respiratory Diseases: a Prospective Cohort Study